Auris Medical Receives FDA and EMA Guidance for Keyzilen® Late-Stage Clinical Development Program
September 13, 2019 09:00 ET
|
Auris Medical AG
Hamilton, Bermuda, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical...